Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Wins Case Against Advanced Materials

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that the Delaware Court of Chancery has ruled in its favor in a trade secrets and breach of contract suit that it had brought against Advanced Materials Technology.

The lawsuit, which was filed in January 2008, centered on the firm's high-performance liquid chromatography technology. In that suit, Agilent alleged that three former employees, who were subsequently employed by AMT, misappropriated Agilent's trade secrets and thereby had breached their confidentiality agreements and fiduciary duties to their former employers.

Agilent said in its statement today that the court ruled that AMT had "illegally used trade secrets and confidential information in developing its Halo HPLC columns."

In addition, Agilent said that the court had ruled that AMT is liable for monetary damages and reasonable attorneys' fees and costs incurred by Agilent as a result of the "willful and malicious conduct."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.